Literature DB >> 32069100

Where Do We Stand with Closed-Loop Systems and Their Challenges?

Melanie Jackson1, Jessica R Castle1.   

Abstract

Treatments for type 1 diabetes have advanced significantly over recent years. There are now multiple hybrid closed-loop systems commercially available and additional systems are in development. Challenges remain, however. This review outlines the recent advances in closed-loop systems and outlines the remaining challenges, including post-prandial hyperglycemia and exercise-related dysglycemia.

Keywords:  Artificial pancreas; Closed-loop; Continuous glucose monitor

Year:  2020        PMID： 32069100      PMCID： PMC7336885          DOI： 10.1089/dia.2019.0469

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN： 1520-9156            Impact factor:   6.118


  51 in total

1.  Incorporating an Exercise Detection, Grading, and Hormone Dosing Algorithm Into the Artificial Pancreas Using Accelerometry and Heart Rate.

Authors:  Peter G Jacobs; Navid Resalat; Joseph El Youssef; Ravi Reddy; Deborah Branigan; Nicholas Preiser; John Condon; Jessica Castle
Journal:  J Diabetes Sci Technol       Date:  2015-10-05

2.  Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.

Authors:  Firas H El-Khatib; Courtney Balliro; Mallory A Hillard; Kendra L Magyar; Laya Ekhlaspour; Manasi Sinha; Debbie Mondesir; Aryan Esmaeili; Celia Hartigan; Michael J Thompson; Samir Malkani; J Paul Lock; David M Harlan; Paula Clinton; Eliana Frank; Darrell M Wilson; Daniel DeSalvo; Lisa Norlander; Trang Ly; Bruce A Buckingham; Jamie Diner; Milana Dezube; Laura A Young; April Goley; M Sue Kirkman; John B Buse; Hui Zheng; Rajendranath R Selagamsetty; Edward R Damiano; Steven J Russell
Journal:  Lancet       Date:  2016-12-20       Impact factor: 79.321

3.  Epidemiology of diabetes phenotypes and prevalent cardiovascular risk factors and diabetes complications in the National Health and Nutrition Examination Survey 2003-2014.

Authors:  Michael P Bancks; Ramon Casanova; Edward W Gregg; Alain G Bertoni
Journal:  Diabetes Res Clin Pract       Date:  2019-11-06       Impact factor: 5.602

4.  DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.

Authors:  Torben Biester; Judith Nir; Kerstin Remus; Alon Farfel; Ido Muller; Sarah Biester; Eran Atlas; Klemen Dovc; Nataša Bratina; Olga Kordonouri; Tadej Battelino; Moshe Philip; Thomas Danne; Revital Nimri
Journal:  Diabetes Obes Metab       Date:  2018-12-21       Impact factor: 6.577

5.  Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide.

Authors:  Jennifer L Sherr; Neha S Patel; Camille I Michaud; Miladys M Palau-Collazo; Michelle A Van Name; William V Tamborlane; Eda Cengiz; Lori R Carria; Eileen M Tichy; Stuart A Weinzimer
Journal:  Diabetes Care       Date:  2016-05-05       Impact factor: 19.112

6.  Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.

Authors:  Stuart A Weinzimer; Garry M Steil; Karena L Swan; Jim Dziura; Natalie Kurtz; William V Tamborlane
Journal:  Diabetes Care       Date:  2008-02-05       Impact factor: 19.112

7.  Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care.

Authors:  Lia Bally; Hood Thabit; Sara Hartnell; Eveline Andereggen; Yue Ruan; Malgorzata E Wilinska; Mark L Evans; Maria M Wertli; Anthony P Coll; Christoph Stettler; Roman Hovorka
Journal:  N Engl J Med       Date:  2018-06-25       Impact factor: 91.245

8.  Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes.

Authors:  Gregory P Forlenza; Orit Pinhas-Hamiel; David R Liljenquist; Dorothy I Shulman; Timothy S Bailey; Bruce W Bode; Michael A Wood; Bruce A Buckingham; Kevin B Kaiserman; John Shin; Suiying Huang; Scott W Lee; Francine R Kaufman
Journal:  Diabetes Technol Ther       Date:  2018-12-26       Impact factor: 6.118

9.  Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study.

Authors:  Marc D Breton; Daniel R Cherñavvsky; Gregory P Forlenza; Mark D DeBoer; Jessica Robic; R Paul Wadwa; Laurel H Messer; Boris P Kovatchev; David M Maahs
Journal:  Diabetes Care       Date:  2017-08-30       Impact factor: 19.112

10.  Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.

Authors:  Jessica R Castle; Joseph El Youssef; Leah M Wilson; Ravi Reddy; Navid Resalat; Deborah Branigan; Katrina Ramsey; Joseph Leitschuh; Uma Rajhbeharrysingh; Brian Senf; Samuel M Sugerman; Virginia Gabo; Peter G Jacobs
Journal:  Diabetes Care       Date:  2018-05-11       Impact factor: 19.112
View more
  1 in total

1.  Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.

Authors:  Dana M Lewis; Sufyan Hussain
Journal:  Diabetes Ther       Date:  2022-08-01       Impact factor: 3.595
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.